Suppr超能文献

[结直肠癌转移。发生率、预后及后果]

[Colorectal cancer metastasis. Frequency, prognosis, and consequences].

作者信息

Hölzel D, Eckel R, Engel J

机构信息

Institut für Med. Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität, Klinikum Grosshadern, Marchioninistrasse 15, Munich, Germany.

出版信息

Chirurg. 2009 Apr;80(4):331-40. doi: 10.1007/s00104-008-1603-x.

Abstract

BACKGROUND

In about 50% of colorectal cancer cases, metastases are responsible for tumour-specific death. This study examines influences on survival after diagnosis of metastases and conclusions that can be drawn from the time pattern of a progressive disease course.

METHODS

The background was provided by Munich Cancer Registry database (Germany). Population-based, good follow-up, high quality of clinical data, and results comparable to those of other cancer registries stand for validity of these data.

RESULTS

Number of positive lymph nodes is the best prognostic factor. However, since metastasis may be initiated before diagnosis of the primary tumour, growth of the primary tumour and the metastases may be two autonomous processes. Thus survival following metastasis is almost unrelated to prognostic factors from the primary tumour, and median survival time after diagnosis of metastases is therefore almost comparable with 17 months. From the distribution of survival time after diagnosis of the primary tumour, the time from initiation of metastases to their diagnosis can be estimated at about 6 years. This means that metastases diagnosed synchronously with the primary tumour (M1) were initiated 6 years before detection of the primary tumour and also that metastases diagnosed during follow-up had already started before therapy of the primary tumour. In consequence, positive lymph nodes are an indicator but not a cause of metastases.

CONCLUSIONS

Specific time relations support the hypothesis that all metastases were initiated before diagnosis of the primary tumour. This hypothetic model has a high explanatory potential, also for evidence of the missing survival benefit from radical lymph node dissection.

摘要

背景

在大约50%的结直肠癌病例中,转移是肿瘤特异性死亡的原因。本研究探讨了对转移诊断后生存的影响,以及从疾病进展过程的时间模式中可以得出的结论。

方法

以慕尼黑癌症登记数据库(德国)为背景。基于人群、随访良好、临床数据质量高以及结果与其他癌症登记处可比,代表了这些数据的有效性。

结果

阳性淋巴结数量是最佳预后因素。然而,由于转移可能在原发性肿瘤诊断之前就已开始,原发性肿瘤和转移灶的生长可能是两个独立的过程。因此,转移后的生存几乎与原发性肿瘤的预后因素无关,转移诊断后的中位生存时间因此几乎与17个月相当。从原发性肿瘤诊断后的生存时间分布来看,从转移开始到诊断的时间估计约为6年。这意味着与原发性肿瘤同时诊断的转移灶(M1)在原发性肿瘤检测前6年就已开始,而且随访期间诊断的转移灶在原发性肿瘤治疗前就已经开始。因此,阳性淋巴结是转移的一个指标而非原因。

结论

特定的时间关系支持了所有转移灶在原发性肿瘤诊断之前就已开始的假说。这个假说模型具有很高的解释潜力,对于根治性淋巴结清扫缺乏生存获益的证据也有解释作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验